Drug Information Association Logo

Patterns of Regulatory Approval for Targeted and Immunotherapeutic Compounds Indicated for the Treatment of Metastatic Melanoma in the US and EU

Time

Wed, Jun 18 7:15AM
W 44

Title

Patterns of Regulatory Approval for Targeted and Immunotherapeutic Compounds Indicated for the Treatment of Metastatic Melanoma in the US and EU

Abstract Summary

We identified the primary and secondary endpoints of pivotal trials for approved mono- and dual-therapeutic compounds for the treatment of metastatic melanoma in the US and EU. All data was collected via publicly available regulatory resources such as clinicaltrials.gov and ema.europa.edu.

Poster Presenter

Jonathan Nguyen Diep
Post-Doctoral Fellow,
Rutgers, The State University of New Jersey
United States